María P. López‐Alberca

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

Dietrich Alexander Ruess, Guus J.J.E. Heynen, Katrin J. Ciecielski et al. · Nature Medicine · 2018 · 363 citations

Tumor Biology, Mutant Kras-driven Cancers, Cancer Cell Biology +4

Competitive Activity-Based Protein Profiling Identifies Aza-β-Lactams as a Versatile Chemotype for Serine Hydrolase Inhibition

Andrea M. Zuhl, Justin T. Mohr, Daniel A. Bachovchin et al. · Journal of the American Chemical Society · 2012 · 60 citations · Full text

Divergent Pathways in the Reaction of Fischer Carbenes and Palladium

María P. López‐Alberca, María J. Mancheño, Israel Fernández et al. · Organic Letters · 2007 · 53 citations

Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors of P. aeruginosa PBP3

Arancha López-Pérez, S. Freischem, Immanuel Grimm et al. · Antibiotics · 2021 · 25 citations · Full text

From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement

Yelena Mostinski, Guus J.J.E. Heynen, María P. López‐Alberca et al. · Journal of Medicinal Chemistry · 2020 · 24 citations · Full text